nod

Latest stories

  • in Health care

    Glenmark Gets CDSCO panel nod for Phase IV CT of COPD drug

    by

    New Delhi: Pharmaceutical major, Glenmark has got the green signal from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to conduct the Phase IV clinical trial of the fixed dose combination (FDC) Glycopyrrolate plus Budesonide plus Formoterol Fumarate dihydrate actuation delivers inhalation aerosol. However, this approval is subjected to […] More

  • in Health care

    Nagaland gets NMC nod to set up its first medical college

    by

    Nagaland has got the approval to set up its first medical college since it got statehood in 1963. In a major boost to medical education in the state, National Medical Commission (NMC), the apex medical body has given approval of letter of Intent for 100 MBBS seats at Nagaland Institute of Medical Sciences & Research […] More

  • in Health care

    Janssen gets European Commission nod for AKEEGA to treat metastatic castration resistant prostate cancer with BRCA1/2 mutations

    by

    Beerse: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced that the European Commission (EC) has granted marketing authorisation for AKEEGA (niraparib and abiraterone acetate [AA]), in the form of a dual action tablet (DAT), given with prednisone or prednisolone, for the treatment of adults with metastatic castration-resistant prostate cancer (mCRPC) and BRCA1/2 mutations (germline […] More

  • in Health care

    USFDA nod to Roche’s Polivy in combination with R-CHP for certain types of previously untreated diffuse large B-cell lymphoma

    by

    Basel: Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Polivy (polatuzumab vedotin-piiq) in combination with Rituxan (rituximab), cyclophosphamide, doxorubicin and prednisone (R-CHP) for the treatment of adult patients who have previously untreated diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS) or high-grade B-cell lymphoma (HGBL) and who have an […] More

  • in Health care

    Zydus Lifesciences bags USFDA nod for pulmonary drug Roflumilast

    by

    Ahmedabad: Pharma major, Zydus Lifesciences Limited, has announced that the company has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Roflumilast Tablets, 250 mcg (USRLD: Daliresp Tablets, 250 mcg). Roflumilast reduces inflammation in the lungs which leads to chronic obstructive pulmonary disease (COPD). It is used to […] More

  • in Health care

    Akums gets CDSCO Panel nod for Phase III CT of FDC Moxifloxacin, Nepafenac ophthalmic solution

    by

    New Delhi: The drug major Akum Pharmaceutical has got the green signal from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) to conduct the Phase III clinical trial study of the fixed-dose combination of Moxifloxacin plus Nepafenac ophthalmic solution. This came after the firm presented the revised Phase III […] More

  • in Health care

    USFDA nod to Zydus Lifesciences Estradiol Transdermal System for postmenopausal osteoporosis prevention

    USFDA approves Zydus Lifesciences Tavaborole Topical Solution to treat fungal toenail infections

    by

    Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Estradiol Transdermal System USP, 0.014 mg/day (weekly) (USRLD: Menostar Transdermal System). Estradiol transdermal system is indicated for prevention of postmenopausal osteoporosis. The drug will be manufactured at the group’s formulation manufacturing facility in Moraiya, […] More

  • in Health care

    J&J Gets CDSCO Panel Nod To Conduct Phase IV CT of Ustekinumab

    J&J Gets CDSCO Panel Nod To Conduct Phase IV CT of Ustekinumab

    by

    New Delhi: In order to evaluate safety of Ustekinumab in Indian subjects with Crohn’s Disease (CD), pharmaceutical major, Johnson & Johnson has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to conduct the Phase IV trial of Ustekinumab Pre-filled syringes 45 mg/0.5 ml, 90 mg/ml […] More

  • in Health care

    NMC Nod to 100 MBBS Seats at GMC Khammam

    NMC Nod to 100 MBBS Seats at GMC Khammam

    by

    Hyderabad: Another 100 MBBS seats are being added to the seat matrix of Telangana as the National Medical Commission (NMC) has given the green signal for Government Medical College in Khammam for the academic year 2023-2024. The apex medical education regulatory body NMC has given its nod for these seats from the academic year 2023-2024. This […] More

  • in Health care

    Lupin Gets CDSCO Panel Nod for Phase IV CT of pulmonary FDC drug

    Lupin Gets CDSCO Panel Nod for Phase IV CT of pulmonary FDC drug

    by

    New Delhi: Pharmaceutical major, Lupin has got the go ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) to conduct a Phase IV clinical trial of the fixed-dose combination Mometasone furoate plus Glycopyrronium bromide plus Indacaterol acetate Inhalation Powder This came after the firm presented the Phase IV clinical […] More

Load More
Congratulations. You've reached the end of the internet.